Sections

Intestinal and Multivisceral Transplantation

Sections Intestinal and Multivisceral Transplantation
Overview
Workup
Treatment
Guidelines
Media Gallery
Tables
References

Workup

Laboratory Studies

Perform a complete blood cell count to rule out anemia and thrombocytopenia. Assess electrolyte levels to look for electrolyte imbalance caused by short bowel syndrome. Perform the following liver function tests to rule out cholestatic liver failure and evaluate liver function:

Serum aspartate aminotransferase (AST)
Serum alanine aminotransferase (ALT)
Alkaline phosphatase (ALP)
Glucose tolerance test

Measure prothrombin time (PT) and activated partial thromboplastin time (aPTT) to rule out coagulation abnormalities and evaluate liver function. Measure the following to rule out deficiencies as the cause of thrombosis:

Protein C
Protein S
Clotting factors
Vitamins B12, K, and D

Perform urinalysis to evaluate renal function and rule out infection. Calculate creatinine clearance to evaluate renal function. Perform a culture to rule out infection. Assess vitamin levels to evaluate nutrition. Perform an absorption test to evaluate intestinal function.

Donor-specific antibodies (DSA) are evaluated to quantify the sensitization.

Citrulline levels are measured to monitor the condition of the intestine.

Additional tests that may be helpful include the following:

Total and direct bilirubin
Serum albumin
Phosphorus and magnesium
Cholesterol and triglycerides
Zinc and selenium
Free and total carnitine
Cytomegalovirus (CMV), Epstein-Barr virus (EBV), hepatitis B virus, hepatitis C virus, and human immunodeficiency virus
Alpha-fetoprotein
Cytotoxic antibody screen

Imaging Studies

Imaging studies include the following^[39]:

Doppler ultrasonography of the extremities to assess the patency of the veins
Doppler ultrasonography of the liver to assess the patency of the vessels
Computed tomography scanning of the abdomen
Upper gastrointestinal (GI) series with small bowel follow-through
Angiography of the abdomen
Magnetic resonance imaging/magnetic resonance angiography
Echocardiography/stress echocardiography
Nuclear medicine studies

Other Tests

Other tests that may be performed include the following:

Electrocardiography
Motility studies (as indicated)
Liver biopsy (as indicated)
Upper gastrointestinal endoscopy

If intestinal failure is functional, the diagnosis depends on the pathological findings and exclusion of other etiologies. Biopsy of the intestine is necessary for the final diagnosis. Perform case-by-case evaluations.

Treatment & Management

Venick RS, Duggan E, Whatley J. Current status of pediatric intestinal transplantation in the United States. Curr Opin Organ Transplant. 2020 Apr. 25 (2):201-207. [QxMD MEDLINE Link].
Clarysse M, Canovai E, Vanuytsel T, Pirenne J. Current state of adult intestinal transplantation in Europe. Curr Opin Organ Transplant. 2020 Apr. 25 (2):176-182. [QxMD MEDLINE Link].
Wilmore DW, Groff DB, Bishop HC, Dudrick SJ. Total parenteral nutrition in infants with catastrophic gastrointestinal anomalies. J Pediatr Surg. 1969 Apr. 4 (2):181-9. [QxMD MEDLINE Link].
Shils ME, Wright WL, Turnbull A, Brescia F. Long-term parenteral nutrition through an external arteriovenous shunt. N Engl J Med. 1970 Aug 13. 283 (7):341-4. [QxMD MEDLINE Link].
Howard L, Heaphey L, Fleming CR, et al. Four years of North American registry home parenteral nutrition outcome data and their implications for patient management. JPEN J Parenter Enteral Nutr. 1991 Jul-Aug. 15(4):384-93. [QxMD MEDLINE Link].
Sauvat F, Fusaro F, Lacaille F, et al. Is intestinal transplantation the future of children with definitive intestinal insufficiency?. Eur J Pediatr Surg. 2008 Dec. 18(6):368-71. [QxMD MEDLINE Link].
Bharadwaj S, Tandon P, Gohel TD, Brown J, Steiger E, Kirby DF, et al. Current status of intestinal and multivisceral transplantation. Gastroenterol Rep (Oxf). 2017 Feb. 5 (1):20-28. [QxMD MEDLINE Link]. [Full Text].
Huard G, Schiano T, Moon J, Iyer K. Choice of Allograft in Patients Requiring Intestinal Transplantation: A Critical Review. Can J Gastroenterol Hepatol. 2017. 2017:1069726. [QxMD MEDLINE Link].
Carrel A. The transplantation of organs. A preliminary communication. JAMA. 1905. 45:1654.
Abu-Elmagd K, Reyes J, Bond G, et al. Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg. 2001 Sep. 234(3):404-16; discussion 416-7. [QxMD MEDLINE Link].
Selvaggi G, Tzakis AG. Small bowel transplantation: technical advances/updates. Curr Opin Organ Transplant. 2009 Jun. 14(3):262-6. [QxMD MEDLINE Link].
National Data: Transplants in the U.S. by Recipient Age. Organ Procurement and Transplantation Network. Available at https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/#. Accessed: February 22, 2021.
Horslen SP, Smith JM, Ahn Y, Skeans MA, Cafarella M, Noreen SM, et al. OPTN/SRTR 2019 Annual Data Report: Intestine. Am J Transplant. 2021 Feb. 21 Suppl 2:316-355. [QxMD MEDLINE Link].
Stanger JD, Oliveira C, Blackmore C, Avitzur Y, Wales PW. The impact of multi-disciplinary intestinal rehabilitation programs on the outcome of pediatric patients with intestinal failure: a systematic review and meta-analysis. J Pediatr Surg. 2013 May. 48(5):983-92. [QxMD MEDLINE Link].
Weih S, Kessler M, Fonouni H, Golriz M, Hafezi M, Mehrabi A, et al. Current practice and future perspectives in the treatment of short bowel syndrome in children--a systematic review. Langenbecks Arch Surg. 2012 Oct. 397 (7):1043-51. [QxMD MEDLINE Link].
Kesseli S, Sudan D. Small Bowel Transplantation. Surg Clin North Am. 2019 Feb. 99 (1):103-116. [QxMD MEDLINE Link].
Colomb V, Goulet O, De Potter S, Ricour C. Liver disease associated with long-term parenteral nutrition in children. Transplant Proc. 1994 Jun. 26(3):1467. [QxMD MEDLINE Link].
Sondheimer JM, Asturias E, Cadnapaphornchai M. Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroenterol Nutr. 1998 Aug. 27(2):131-7. [QxMD MEDLINE Link].
Chan S, McCowen KC, Bistrian BR, et al. Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home total parenteral nutrition. Surgery. 1999 Jul. 126(1):28-34. [QxMD MEDLINE Link].
Wasa M, Takagi Y, Sando K, et al. Long-term outcome of short bowel syndrome in adult and pediatric patients. JPEN J Parenter Enteral Nutr. 1999 Sep-Oct. 23(5 Suppl):S110-2. [QxMD MEDLINE Link].
Cavicchi M, Beau P, Crenn P, et al. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med. 2000 Apr 4. 132(7):525-32. [QxMD MEDLINE Link].
Bowyer BA, Fleming CR, Ludwig J, et al. Does long-term home parenteral nutrition in adult patients cause chronic liver disease?. JPEN J Parenter Enteral Nutr. 1985 Jan-Feb. 9(1):11-7. [QxMD MEDLINE Link].
Stokes MA, Irving MH. Mortality in patients on home parenteral nutrition. JPEN J Parenter Enteral Nutr. 1989 Mar-Apr. 13(2):172-5. [QxMD MEDLINE Link].
Wolf A, Pohlandt F. Bacterial infection: the main cause of acute cholestasis in newborn infants receiving short-term parenteral nutrition. J Pediatr Gastroenterol Nutr. 1989 Apr. 8(3):297-303. [QxMD MEDLINE Link].
Williams N, Scott NA, Irving MH. Catheter-related morbidity in patients on home parenteral nutrition: implications for small bowel transplantation. Ann R Coll Surg Engl. 1994 Nov. 76(6):384-6. [QxMD MEDLINE Link].
Burnes JU, O'Keefe SJ, Fleming CR, et al. Home parenteral nutrition--a 3-year analysis of clinical and laboratory monitoring. JPEN J Parenter Enteral Nutr. 1992 Jul-Aug. 16(4):327-32. [QxMD MEDLINE Link].
Broviac JW, Cole JJ, Scribner BH. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet. 1973 Apr. 136(4):602-6. [QxMD MEDLINE Link].
Flowers RH 3rd, Schwenzer KJ, Kopel RF, et al. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. A randomized, controlled trial. JAMA. 1989 Feb 10. 261(6):878-83. [QxMD MEDLINE Link].
Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med. 2000 Mar 7. 132(5):391-402. [QxMD MEDLINE Link].
Grant D. Intestinal transplantation: 1997 report of the international registry. Intestinal Transplant Registry. Transplantation. 1999 Apr 15. 67(7):1061-4. [QxMD MEDLINE Link].
Howard L, Hassan N. Home parenteral nutrition. 25 years later. Gastroenterol Clin North Am. 1998 Jun. 27(2):481-512. [QxMD MEDLINE Link].
Pironi L, Joly F, Forbes A, et al. Long-term follow-up of patients on home parenteral nutrition in Europe: implications for intestinal transplantation. Gut. 2011 Jan. 60(1):17-25. [QxMD MEDLINE Link].
Desai CS, Khan KM, Gruessner AC, Fishbein TM, Gruessner RW. Intestinal retransplantation: analysis of Organ Procurement and Transplantation Network database. Transplantation. 2012 Jan 15. 93(1):120-5. [QxMD MEDLINE Link].
Lacaille F, Vass N, Sauvat F, et al. Long-term outcome, growth and digestive function in children 2 to 18 years after intestinal transplantation. Gut. 2008 Apr. 57(4):455-61. [QxMD MEDLINE Link].
Kosmach B, Tarbell S, Reyes J, Todo S. "Munchausen by proxy" syndrome in a small bowel transplant recipient. Transplant Proc. 1996 Oct. 28(5):2790-1. [QxMD MEDLINE Link].
Sudan DL, Kaufman SS, Shaw BW Jr, et al. Isolated intestinal transplantation for intestinal failure. Am J Gastroenterol. 2000 Jun. 95(6):1506-15. [QxMD MEDLINE Link].
Trevizol AP, David AI, Yamashita ET, Pecora RA, D'Albuquerque LA. Intestinal and multivisceral retransplantation results: literature review. Transplant Proc. 2013 Apr. 45 (3):1133-6. [QxMD MEDLINE Link].
Lacaille F, Irtan S, Dupic L, Talbotec C, Lesage F, Colomb V, et al. Twenty-eight years of intestinal transplantation in Paris: experience of the oldest European center. Transpl Int. 2017 Feb. 30 (2):178-186. [QxMD MEDLINE Link].
Rees MA, Amesur NB, Cruz RJ, Borhani AA, Abu-Elmagd KM, Costa G, et al. Imaging of Intestinal and Multivisceral Transplantation. Radiographics. 2018 Mar-Apr. 38 (2):413-432. [QxMD MEDLINE Link].
Asfar S, Atkison P, Ghent C, et al. Small bowel transplantation. A life-saving option for selected patients with intestinal failure. Dig Dis Sci. 1996 May. 41(5):875-83. [QxMD MEDLINE Link].
Quigley EM. Small intestinal transplantation: reflections on an evolving approach to intestinal failure. Gastroenterology. 1996 Jun. 110(6):2009-12. [QxMD MEDLINE Link].
Drucker DJ. The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome. ACS Pharmacol Transl Sci. 2019 Apr 12. 2 (2):134-142. [QxMD MEDLINE Link]. [Full Text].
Fishbein TM, Schiano T, LeLeiko N, et al. An integrated approach to intestinal failure: results of a new program with total parenteral nutrition, bowel rehabilitation, and transplantation. J Gastrointest Surg. 2002 Jul-Aug. 6(4):554-62.
Sudan D, DiBaise J, Torres C, Thompson J, Raynor S, Gilroy R, et al. A multidisciplinary approach to the treatment of intestinal failure. J Gastrointest Surg. 2005 Feb. 9 (2):165-76; discussion 176-7. [QxMD MEDLINE Link].
Matarese LE, Seidner DL, Steiger E, Fazio V. Practical guide to intestinal rehabilitation for postresection intestinal failure: a case study. Nutr Clin Pract. 2005. 20(5):551-8. [QxMD MEDLINE Link].
Higham SE, Read NW. Effect of ingestion of fat on ileostomy effluent. Gut. 1990. 31(4):435-8. [QxMD MEDLINE Link].
Haderslev KV, Tjellesen L, Sorensen HA, Staun M. Effect of cyclical intravenous clodronate therapy on bone mineral density and markers of bone turnover in patients receiving home parenteral nutrition. Am J Clin Nutr. 2002. 76(2):482-8. [QxMD MEDLINE Link].
Byrne TA, Wilmore DW, Iyer K. Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome: a prospective, randomized, placebo-controlled, double-blind clinical trial. Ann Surg. 2005. 242(5):655-61. [QxMD MEDLINE Link].
Jeppesen PB, Sanguinetti EL, Buchman A, et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut. 2005 Sep. 54(9):1224-31.
Bianchi A. Autologous gastrointestinal reconstruction. Semin Pediatr Surg. 1995 Feb. 4(1):54-9.
Kim HB, Lee PW, Garza J, et al. Serial transverse enteroplasty for short bowel syndrome: a case report. J Pediatr Surg. 2003 Jun. 38(6):881-5.
DeRoover A, Langnas A. Surgical methods of small bowel transplantation. Curr Opin Organ Transplant. 1999. 4(4):335-42.
Fishbein TM, Florman S, Gondolesi G, et al. Intestinal transplantation before and after the introduction of sirolimus. Transplantation. 2002. 73(10):1538-42. [QxMD MEDLINE Link].
Kato T, Selvaggi G, Gaynor JJ, et al. Inclusion of donor colon and ileocecal valve in intestinal transplantation. Transplantation. 2008 Jul 27. 86(2):293-7. [QxMD MEDLINE Link].
Matsumoto CS, Kaufman SS, Fishbein TM. Inclusion of the colon in intestinal transplantation. Curr Opin Organ Transplant. 2011 Jun. 16(3):312-5. [QxMD MEDLINE Link].
O'Keefe SJ, Emerling M, Koritsky D, Martin D, Stamos J, Kandil H, et al. Nutrition and quality of life following small intestinal transplantation. Am J Gastroenterol. May/2007. 102(5):1093-100. [QxMD MEDLINE Link].
Todo S, Reyes J, Furukawa H, et al. Outcome analysis of 71 clinical intestinal transplantations. Ann Surg. 1995 Sep. 222(3):270-80; discussion 280-2. [QxMD MEDLINE Link].
Furukawa H, Kusne S, Abu-Elmagd K, et al. Effect of CMV serology on outcome after clinical intestinal transplantation. Transplant Proc. 1996 Oct. 28(5):2780-1. [QxMD MEDLINE Link].
Reynolds DW, Stagno S, Reynolds R, Alford CA Jr. Perinatal cytomegalovirus infection: influence of placentally transferred maternal antibody. J Infect Dis. 1978 May. 137(5):564-7. [QxMD MEDLINE Link].
Todo S, Tzakis AG, Abu-Elmagd K, Reyes J, Nakamura K, Casavilla A, et al. Intestinal transplantation in composite visceral grafts or alone. Ann Surg. 1992 Sep. 216 (3):223-33; discussion 233-4. [QxMD MEDLINE Link].
Abu-Elmagd K, Fung J, Bueno J, Martin D, Madariaga JR, Mazariegos G, et al. Logistics and technique for procurement of intestinal, pancreatic, and hepatic grafts from the same donor. Ann Surg. 2000 Nov. 232 (5):680-7. [QxMD MEDLINE Link].
Karatzas T, Khan F, Tzakis AG. Clinical intestinal transplantation: experience in Miami. Transplant Proc. 1997 May. 29(3):1787-9. [QxMD MEDLINE Link].
Reyes J, Bueno J, Kocoshis S, et al. Current status of intestinal transplantation in children. J Pediatr Surg. 1998 Feb. 33(2):243-54. [QxMD MEDLINE Link].
Herlenius G, Fagerlind M, Krantz M, et al. Chronic kidney disease--a common and serious complication after intestinal transplantation. Transplantation. 2008 Jul 15. 86(1):108-13. [QxMD MEDLINE Link].
Abu-Elmagd K, Reyes J, Todo S, et al. Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg. 1998 May. 186(5):512-25; discussion 525-7. [QxMD MEDLINE Link].
Sudan DL, Kaufman S, Horslen S, et al. Incidence, timing, and histologic grade of acute rejection in small bowel transplant recipients. Transplant Proc. 2000 Sep. 32(6):1199. [QxMD MEDLINE Link].
Rana A, Robles S, Russo MJ, et al. The combined organ effect: protection against rejection?. Ann Surg. 2008 Nov. 248(5):871-9. [QxMD MEDLINE Link].
Andres AM, Lopez Santamaría M, Ramos E, Hernandez F, Prieto G, Encinas J, et al. The use of sirolimus as a rescue therapy in pediatric intestinal transplant recipients. Pediatr Transplant. 2010 Nov. 14(7):931-5. [QxMD MEDLINE Link].
Kusne S, Furukawa H, Abu-Elmagd K, et al. Infectious complications after small bowel transplantation in adults: an update. Transplant Proc. 1996 Oct. 28(5):2761-2. [QxMD MEDLINE Link].
Green M, Reyes J, Nour B, et al. Early infectious complications of liver-intestinal transplantation in children: preliminary analysis. Transplant Proc. 1994 Jun. 26(3):1420-1. [QxMD MEDLINE Link].
Manez R, Kusne S, Green M, et al. Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. Transplantation. 1995 Apr 15. 59(7):1010-4. [QxMD MEDLINE Link].
Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol. 1988 Oct. 133(1):173-92. [QxMD MEDLINE Link].
Nalesnik M, Reyes J, Mazieriegos G, et al. Posttransplant lymphoproliferative disorders (PTLD) in small bowel allograft recipients. Presented at: Sixth International Small Bowel Transplant Symposium. University of Pittsburgh Medical Center; Pittsburgh, Pa:. 1999.
Elstrom RL, Andreadis C, Aqui NA, et al. Treatment of PTLD with rituximab or chemotherapy. Am J Transplant. 2006 Mar. 6(3):569-76. [QxMD MEDLINE Link].
Lee JJ, Lam MS, Rosenberg A. Role of chemotherapy and rituximab for treatment of posttransplant lymphoproliferative disorder in solid organ transplantation. Ann Pharmacother. 2007 Oct. 41(10):1648-59. [QxMD MEDLINE Link].
Vianna RM, Mangus RS, Fridell JA, Weigman S, Kazimi M, Tector J. Induction immunosuppression with thymoglobulin and rituximab in intestinal and multivisceral transplantation. Transplantation. 2008 May 15. 85(9):1290-3. [QxMD MEDLINE Link].
Pirenne J, Gruessner AC, Benedetti E, et al. Donor-specific unmodified bone marrow transfusion does not facilitate intestinal engraftment after bowel transplantation in a porcine model. Surgery. 1997 Jan. 121(1):79-88. [QxMD MEDLINE Link].
Sharkey LM, Peacock S, Russell NK, Middleton SJ, Butler AJ. Graft versus host disease after multivisceral transplantation: A UK center experience and update on management. Clin Transplant. 2018 Mar 15. e13239. [QxMD MEDLINE Link].
Matsumoto S, Tanaka S, Orita K. Effect of donor pretreatment on graft-versus-host disease (GVHD) after rat small-bowel transplantation (SBTX). Transplant Proc. 1994 Aug. 26(4):2306-8. [QxMD MEDLINE Link].
Bacigalupo A, van Lint MT, Frassoni F, et al. High dose bolus methylprednisolone for the treatment of acute graft versus host disease. Blood. 1983 Mar. 46(3):125-32. [QxMD MEDLINE Link].
Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med. 2003. 349(10):931-40. [QxMD MEDLINE Link].
Howard L, Ament M, Fleming CR, et al. Current use and clinical outcome of home parenteral and enteral nutrition therapies in the United States. Gastroenterology. 1995 Aug. 109(2):355-65. [QxMD MEDLINE Link].
Reyes J, Fishbein T, Bueno J, et al. Reduced-size orthotopic composite liver-intestinal allograft. Transplantation. 1998 Aug 27. 66(4):489-92. [QxMD MEDLINE Link].
de Ville de Goyet J, Mitchell A, Mayer AD, et al. En block combined reduced-liver and small bowel transplants: from large donors to small children. Transplantation. 2000 Feb 27. 69(4):555-9. [QxMD MEDLINE Link].
Sigalet DL, Williams DC, Garola R, et al. Impact of FK506 and steroids on adaptation after intestinal resection or segmental transplantation. Pediatr Transplant. 2000 Feb. 4(1):12-20. [QxMD MEDLINE Link].
Sudan DL, Iverson A, Weseman RA, et al. Assessment of function, growth and development, and long-term quality of life after small bowel transplantation. Transplant Proc. 2000 Sep. 32(6):1211-2. [QxMD MEDLINE Link].
Muiesan P, Dhawan A, Novelli M, et al. Isolated liver transplant and sequential small bowel transplantation for intestinal failure and related liver disease in children. Transplantation. 2000 Jun 15. 69(11):2323-6. [QxMD MEDLINE Link].
Tzakis AG, Kato T, Nishida S, et al. Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation. Transplantation. 2003 Apr 27. 75(8):1227-31.
Patil PB, Chougule PB, Kumar VK, Almström S, Bäckdahl H, Banerjee D. Recellularization of acellular human small intestine using bone marrow stem cells. Stem Cells Transl Med. 2013 Apr. 2(4):307-15. [QxMD MEDLINE Link].
Spurrier RG, Grikscheit TC. Tissue engineering the small intestine. Clin Gastroenterol Hepatol. 2013 Apr. 11(4):354-8. [QxMD MEDLINE Link].
Grikscheit TC, Siddique A, Ochoa ER, Srinivasan A, Alsberg E, Hodin RA. Tissue-engineered small intestine improves recovery after massive small bowel resection. Ann Surg. 2004 Nov. 240(5):748-54. [QxMD MEDLINE Link].
[Guideline] Kaufman SS, Atkinson JB, Bianchi A, Goulet OJ, Grant D, Langnas AN, et al. Indications for pediatric intestinal transplantation: a position paper of the American Society of Transplantation. Pediatr Transplant. 2001 Apr. 5 (2):80-7. [QxMD MEDLINE Link].
[Guideline] Pironi L, Arends J, Bozzetti F, Cuerda C, Gillanders L, Jeppesen PB, et al. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr. 2016 Apr. 35 (2):247-307. [QxMD MEDLINE Link]. [Full Text].
Abu-Elmagd KM, Reyes J, Fung JJ, et al. Evolution of clinical intestinal transplantation: improved outcome and cost effectiveness. Transplant Proc. 1999 Feb-Mar. 31(1-2):582-4. [QxMD MEDLINE Link].
Gupte GL, Beath SV, Protheroe S, et al. Improved outcome of referrals for intestinal transplantation in the UK. Arch Dis Child. 2007. 92(2):147-52. [QxMD MEDLINE Link].
Schalamon J, Mayr JM, Hollwarth ME. Mortality and economics in short bowel syndrome. Best Pract Res Clin Gastroenterol. 2003. 17(6):931-42. [QxMD MEDLINE Link].
Abu-Elmagd KM, Mazariegos G. Intestinal transplantation and the European implication: impact of experience and study design. Gut. 2012 Jan. 61(1):166; author reply 167. [QxMD MEDLINE Link].
Cohen Z, Silverman RE, Wassef R, et al. Small intestinal transplantation using cyclosporine. Report of a case. Transplantation. 1986 Dec. 42(6):613-21. [QxMD MEDLINE Link].
Masetti M, Rodriguez MM, Thompson JF, et al. Multivisceral transplantation for megacystis microcolon intestinal hypoperistalsis syndrome. Transplantation. 1999 Jul 27. 68(2):228-32. [QxMD MEDLINE Link].
Rovera GM, DiMartini A, Schoen RE, et al. Quality of life of patients after intestinal transplantation. Transplantation. 1998 Nov 15. 66(9):1141-5. [QxMD MEDLINE Link].
Ngo KD, Farmer DG, McDiarmid SV, Artavia K, Ament ME, Vargas J, et al. Pediatric health-related quality of life after intestinal transplantation. Pediatr Transplant. 2011 Dec. 15(8):849-54. [QxMD MEDLINE Link].
Grant D, Abu-Elmagd K, Reyes J, et al. 2003 report of the intestine transplant registry: a new era has dawned. Ann Surg. 2005 Apr. 241(4):607-13.
Kato T, Selvaggi G, Gaynor JJ, et al. Inclusion of donor colon and ileocecal valve in intestinal transplantation. Transplantation. 2008 Jul 27. 86(2):293-7. [QxMD MEDLINE Link].
Abu-Elmagd KM. Intestinal transplantation for short bowel syndrome and gastrointestinal failure: current consensus, rewarding outcomes, and practical guidelines. Gastroenterology. 2006 Feb. 130(2 Suppl 1):S132-7.
Alqahtani SA. Update in liver transplantation. Discov Med. 2012 Aug. 14(75):133-41. [QxMD MEDLINE Link].
Bittermann T, Makar G, Goldberg D. Exception point applications for 15 points: an unintended consequence of the share 15 policy. Liver Transpl. 2012 Nov. 18(11):1302-9. [QxMD MEDLINE Link].
Buchman AL. Etiology and initial management of short bowel syndrome. Gastroenterology. 2006 Feb. 130(2 Suppl 1):S5-S15.
Buchman AL, Iyer K, Fryer J. Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation. Hepatology. 2006 Jan. 43(1):9-19.
Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology. 2003 Apr. 124(4):1111-34.
Cai J. Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009). Clin Transpl. 2009. 83-101. [QxMD MEDLINE Link].
Colomb V, De Potter S, Goulet O, et al. Potential candidates for small bowel transplantation in pediatric patients on home parenteral nutrition. Transplant Proc. 1996 Oct. 28(5):2698. [QxMD MEDLINE Link].
Connor FL, Di Lorenzo C. Chronic intestinal pseudo-obstruction: assessment and management. Gastroenterology. 2006 Feb. 130(2 Suppl 1):S29-36.
Fujishiro J, Pech TC, Finger TF, Praktinjo M, Stoffels B, Standop J. Influence of immunosuppression on alloresponse, inflammation and contractile function of graft after intestinal transplantation. Am J Transplant. 2010 Jul. 10(7):1545-55. [QxMD MEDLINE Link].
Gotthardt DN, Gauss A, Zech U, Mehrabi A, Weiss KH, Sauer P. Indications for intestinal transplantation: recognizing the scope and limits of total parenteral nutrition. Clin Transplant. 2013 Jul-Aug. 27 Suppl 25:49-55. [QxMD MEDLINE Link].
Gracz AD, Magness ST. Sry-box (Sox) transcription factors in gastrointestinal physiology and disease. Am J Physiol Gastrointest Liver Physiol. 2011 Apr. 300(4):G503-15. [QxMD MEDLINE Link].
Gross TG, Hinrichs SH, Winner J, et al. Treatment of post-transplant lymphoproliferative disease (PTLD) following solid organ transplantation with low-dose chemotherapy. Ann Oncol. 1998 Mar. 9(3):339-40. [QxMD MEDLINE Link].
Hanto DW, Fishbein TM, Pinson CW, et al. Liver and intestine transplantation: summary analysis, 1994-2003. Am J Transplant. 2005 Apr. 5(4 Pt 2):916-33.
Horslen SP, Kaufman SS, Sudan DL, et al. Isolated liver transplantation in infants with total parenteral nutrition-associated end-stage liver disease. Transplant Proc. 2000 Sep. 32(6):1241. [QxMD MEDLINE Link].
Howard L, Malone M. Current status of home parenteral nutrition in the United States. Transplant Proc. 1996 Oct. 28(5):2691-5. [QxMD MEDLINE Link].
Iyer KR, Horslen S, Torres C, et al. Functional liver recovery parallels autologous gut salvage in short bowel syndrome. J Pediatr Surg. 2004 Mar. 39(3):340-4; discussion 340-4.
Kaplan J, Han L, Halgrimson W, Wang E, Fryer J. The impact of MELD/PELD revisions on the mortality of liver-intestine transplantation candidates. Am J Transplant. 2011 Sep. 11(9):1896-904. [QxMD MEDLINE Link].
Kato T, O'Brien CB, Nishida S, et al. The first case report of the use of a zoom videoendoscope for the evaluation of small bowel graft mucosa in a human after intestinal transplantation. Gastrointest Endosc. 1999 Aug. 50(2):257-61. [QxMD MEDLINE Link].
Kimura T, Lauro A, Cescon M, et al. Impact of induction therapy on bacterial infections and long-term outcome in adult intestinal and multivisceral transplantation: a comparison of two different induction protocols: daclizumab vs. alemtuzumab. Clin Transplant. 2009 Jun-Jul. 23(3):420-5. [QxMD MEDLINE Link].
Lawrence JP, Dunn SP, Billmire DF, et al. Isolated liver transplantation for liver failure in patients with short bowel syndrome. J Pediatr Surg. 1994 Jun. 29(6):751-3. [QxMD MEDLINE Link].
Lee RG, Nakamura K, Tsamandas AC, et al. Pathology of human intestinal transplantation. Gastroenterology. 1996 Jun. 110(6):1820-34. [QxMD MEDLINE Link].
Mangus RS, Tector AJ, Kubal CA, Fridell JA, Vianna RM. Multivisceral transplantation: expanding indications and improving outcomes. J Gastrointest Surg. 2013 Jan. 17(1):179-86; discussion p.186-7. [QxMD MEDLINE Link].
Matarese LE, O'Keefe SJ, Kandil HM, Bond G, Costa G, Abu-Elmagd K. Short bowel syndrome: clinical guidelines for nutrition management. Nutr Clin Pract. 2005. 20(5):493-502. [QxMD MEDLINE Link].
Mazariegos GV, Soltys K, Bond G, et al. Pediatric intestinal retransplantation: techniques, management, and outcomes. Transplantation. 2008 Dec 27. 86(12):1777-82. [QxMD MEDLINE Link].
Messing B, Lemann M, Landais P, et al. Prognosis of patients with nonmalignant chronic intestinal failure receiving long-term home parenteral nutrition. Gastroenterology. 1995 Apr. 108(4):1005-10. [QxMD MEDLINE Link].
Murase N, Ye Q, Lee RG, et al. Immunomodulation of intestinal transplant with allograft irradiation and simultaneous donor bone marrow infusion. Transplant Proc. 1999 Feb-Mar. 31(1-2):565-6.
O'Keefe SJ, Buchman AL, Fishbein TM, et al. Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin Gastroenterol Hepatol. 2006 Jan. 4(1):6-10.
Reyes J, Green M, Bueno J, et al. Epstein Barr virus associated posttransplant lymphoproliferative disease after intestinal transplantation. Transplant Proc. 1996 Oct. 28(5):2768-9. [QxMD MEDLINE Link].
Reyes JD. Intestinal transplantation: an unexpected journey. J Pediatr Surg. 2014 Jan. 49(1):13-8. [QxMD MEDLINE Link].
Saginur M, Thiesen A, Lacson A, Bigam D, Yap J. Small intestinal transplant mucosal necrosis associated with enteral sodium polystyrene sulfonate administration. Am J Transplant. 2012 Nov. 12(11):3152-4. [QxMD MEDLINE Link].
Scolapio JS. Short bowel syndrome: recent clinical outcomes with growth hormone. Gastroenterology. 2006 Feb. 130(2 Suppl 1):S122-6.
Seguy D, Vahedi K, Kapel N, et al. Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study. Gastroenterology. 2003 Feb. 124(2):293-302.
Shaffer D, Maki T, DeMichele SJ, et al. Studies in small bowel transplantation. Prevention of graft-versus-host disease with preservation of allograft function by donor pretreatment with antilymphocyte serum. Transplantation. 1988 Feb. 45(2):262-9. [QxMD MEDLINE Link].
Sigurdsson L, Reyes J, Kocoshis SA, et al. Intestinal transplantation in children with chronic intestinal pseudo- obstruction. Gut. 1999 Oct. 45(4):570-4. [QxMD MEDLINE Link].
Sindhi R, Fox IJ, Heffron T, et al. Procurement and preparation of human isolated small intestinal grafts for transplantation. Transplantation. 1995 Oct 27. 60(8):771-3. [QxMD MEDLINE Link].
Small bowel transplant: an evidence-based analysis. Ont Health Technol Assess Ser. 2003. 3(1):1-72. [QxMD MEDLINE Link].
Stanger JD, Oliveira C, Blackmore C, Avitzur Y, Wales PW. The impact of multi-disciplinary intestinal rehabilitation programs on the outcome of pediatric patients with intestinal failure: a systematic review and meta-analysis. J Pediatr Surg. 2013 May. 48(5):983-92. [QxMD MEDLINE Link].
Sudan D. Cost and quality of life after intestinal transplantation. Gastroenterology. 2006 Feb. 130 (2 Suppl 1):S158-62. [QxMD MEDLINE Link].
Sudan DL, Iyer KR, DeRoover A, et al. A new technique for combined liver/small intestinal transplantation. Transplantation. 2001 Dec 15. 72(11):1846-8. [QxMD MEDLINE Link].
Thompson JS, DiBaise JK, Iyer KR, et al. Postoperative short bowel syndrome. J Am Coll Surg. 2005 Jul. 201(1):85-9.
Vikram HR, Smilack JD, Leighton JA, Crowell MD, De Petris G. Emergence of gastrointestinal basidiobolomycosis in the United States, with a review of worldwide cases. Clin Infect Dis. 2012 Jun. 54(12):1685-91. [QxMD MEDLINE Link]. [Full Text].
Wisecarver JL, Cattral MS, Langnas AN, et al. Transfusion-induced graft-versus-host disease after liver transplantation. Documentation using polymerase chain reaction with HLA- DR sequence-specific primers. Transplantation. 1994 Aug 15. 58(3):269-71. [QxMD MEDLINE Link].

Media Gallery

Anatomy of the donor operation, with procurement of the liver, small bowel, pancreas, and spleen en bloc (AO, thoracic aorta; HA, hepatic artery; PV, portal vein; CBD, common bile duct; D1, first part of the duodenum; TI, terminal ileum).
Small bowel recipient operation (AOI, interposition graft of aorta; AOII, Carrel patch bearing celiac trunk and superior mesenteric artery; AOIII, aortic end oversewn below superior mesenteric artery take-off; SV, native splenic vein; P, pancreas, with duct and parenchymal edge oversewn; PB, proximal bowel anastomosis; DB, distal ileocolonic anastomosis; LS, diverting loop ileostomy).
Intestinal transplantation: Back table operation with mesenteric vessels held within the forceps and the donor intestine within preservation solution.
Intestinal graft within the abdominal cavity of the recipient at the time of revascularization.
Revascularized bowel prior to closure. In the lower right corner the anastomosis between the donor small bowel and recipient remnant colon can be seen.
Picture of the liver and small bowel allograft. The liver is to the left of the picture, and the spleen can be seen lying within the loops of the small bowel (spleen is removed later).
Removal of the native liver. Left behind is the cavity into which the liver and small bowel allograft will be placed.
Postrevascularization image of the liver and small bowel allograft.
The allograft, prior to closure, positioned within the recipient's abdomen. The wedge-shaped excision (biopsy site) seen on the donor organ was performed at organ procurement. These biopsies are selectively performed to review the suitability of organs in instances where issues of suitability are raised.
Survival figures 2007. Image courtesy of the Intestinal Transplantation Registry (ITR).
Parenteral-nutrition related cholestasis. (This is a reversible pathology at this point, in the absence of fibrosis.)
Intestinal transplants by year in the United States. Data source: Organ Procurement and Transplantation Network https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/#
Intestinal Transplantation. A) Pretransplant diagnosis-children, B) Pretransplant diagnosis-adults
Survival by era
Survival (2004–2009) by graft type
Survival (2004–2009) by pretransplant status
Graft survival by the liver, included or not (1985–2009)

of 21

Author

Richard K Gilroy, MBBS, FRACP Associate Professor, Medical Director of Liver Transplantation and Hepatology, Department of Internal Medicine, Kansas University Medical Center

Disclosure: Received salary from gilead, NPS pharmaceuticals, salix pharmaceuticals, AbbVie for speaking and teaching.

Coauthor(s)

Jean Frederick Botha, MBBCh Assistant Professor, Transplant Surgeon, Department of Surgery, University of Nebraska Medical Center

Disclosure: Nothing to disclose.

Debra L Sudan, MD Professor of Surgery, Chief, Abdominal Transplant Surgery, Vice Chair of Clinical Operations, Department of Surgery, Duke University School of Medicine

Debra L Sudan, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Surgeons, American Society of Transplant Surgeons, American Society of Transplantation, American Surgical Association, Association for Academic Surgery, Nebraska Medical Association, Society for Surgery of the Alimentary Tract, Society of University Surgeons, Association of Women Surgeons, Association of Women Surgeons, International Liver Transplantation Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Chief Editor

Stuart M Greenstein, MD Professor of Surgery, Albert Einstein College of Medicine; Consulting Surgeon, Department of Surgery, Division of Transplantation, Montefiore Medical Center

Stuart M Greenstein, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Surgeons, American Society of Transplant Surgeons, American Society of Transplantation, Association for Academic Surgery, International College of Surgeons, Medical Society of New Jersey, National Kidney Foundation, New York Academy of Sciences, Southeastern Surgical Congress

Disclosure: Nothing to disclose.

Acknowledgements

Sandeep Mukherjee, MB, BCh, MPH, FRCPC Associate Professor, Department of Internal Medicine, Section of Gastroenterology and Hepatology, University of Nebraska Medical Center; Consulting Staff, Section of Gastroenterology and Hepatology, Veteran Affairs Medical Center

Sandeep Mukherjee, MB, BCh, MPH, FRCPC is a member of the following medical societies: Royal College of Physicians and Surgeons of Canada

Disclosure: Merck Honoraria Speaking and teaching; Ikaria Pharmaceuticals Honoraria Board membership

Acknowledgments

The authors wish to thank Dr. Wendy Grant, Assistant Professor of Surgery, Section of Transplantation, University of Nebraska Medical Center, for providing the multimedia images in this article and the Intestinal Transplantation Registry (ITR) for providing the charts in this article.

Sections Intestinal and Multivisceral Transplantation
Overview
Workup
Treatment
Guidelines
Media Gallery
Tables
References

Medication	Days 2-29	Days 30-89	Days 90-179	Days 180-365	After 1 year
Tacrolimus (monotherapy levels)	15-20 ng/mL	12-15 ng/mL	10-12 ng/mL	7-10 ng/mL	Taper to around 5 ng/mL
Tacrolimus (in combination levels)	10-15 ng/mL	8-12 ng/mL	8-10 ng/mL	5-8 ng/mL	2.5-5 ng/mL
Prednisone (dose)	20 mg	15 mg	10 mg	7.5 mg	5 mg
Rapamycin (to be used only in combination with tacrolimus)	6-10 ng/mL	5-8 ng/mL	5-8 ng/mL	5-8 ng/mL	5-8 ng/mL
Mycophenolic acid (suggested dose as listed and to be used only in combination with tacrolimus; dose listed is adult dose; intolerance may be managed by lowering dose)	1000 mg bid	1000 mg bid	Cease unless renal indication exists	...	...

Intestinal and Multivisceral Transplantation Workup

Laboratory Studies

Imaging Studies

Other Tests

References

Tables

Contributor Information and Disclosures

What would you like to print?